InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-47.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the full record of transactions filed by Wendel Bruce, Director. Director active across 1 company, notably GT Biopharma, Inc.. Aggregated, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 16 November 2020. The latest transaction was disclosed on 16 November 2020 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations1 total
3,268 shares@ US$3.140.043% mcap50.0% of flowCommon StockSEC:0001654954-21-010887:0
Ideal exit: 13 Aug 2021 (T+270)
1 of 1 declaration
About Wendel Bruce
Bruce Wendel is a Director at GT Biopharma, Inc. In this role, he brings his expertise to guide the company's strategy and participate in key board decisions.
